mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |